Literature DB >> 20525107

Effect of diabetes mellitus on protein-energy wasting and protein wasting in end-stage renal disease.

Nazanin Noori1, Joel D Kopple.   

Abstract

Protein wasting (PW) or protein-energy wasting (PEW) occurs commonly in patients with diabetes mellitus who have end-stage renal disease (ESRD) and are undergoing maintenance dialysis (MD) therapy. Some but not all studies indicate that PW or PEW is more prevalent in diabetic when compared with nondiabetic MD patients and that diabetic patients commencing maintenance hemodialysis (MHD) are more likely to lose fat-free, edema-free weight than are incident nondiabetic MHD patients. The causes of PW and PEW in diabetic MD patients are probably largely similar to those of nondiabetic MD patients. These causes include anorexia, reduced food intake, concurrent illnesses particularly when associated with inflammatory processes, physical or mental debility, removal of nutrients by dialysis procedure, acidemia, possibly physical deconditioning, and oxidant and carbonyl stress. However, diabetic MD patients are also at greater risk for PW or PEW from comorbidities related to diabetes per se. These disorders include ischemic vascular disease, hypertension, gastrointestinal dysfunction, and neuropathy. Metabolic disorders such as insulin deficiency or resistance to the actions of insulin, and elevated levels of counterregulatory hormones may also contribute to PW or PEW in diabetic MD patients. Mechanisms by which these metabolic disorders in diabetic ESRD patients may cause PW or PEW are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20525107     DOI: 10.1111/j.1525-139X.2010.00705.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  3 in total

1.  A prospective cohort study of risk prediction in simultaneous pancreas and kidney transplantation.

Authors:  H A Khambalia; Z Moinuddin; A M Summers; A Tavakoli; R Pararajasingam; T Campbell; R Dhanda; B Forgacs; T Augustine; D van Dellen
Journal:  Ann R Coll Surg Engl       Date:  2015-08-14       Impact factor: 1.891

2.  Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients.

Authors:  Yu-Li Lin; Shu-Yuan Chen; Yu-Hsien Lai; Chih-Hsien Wang; Chiu-Huang Kuo; Hung-Hsiang Liou; Bang-Gee Hsu
Journal:  BMC Nephrol       Date:  2019-02-14       Impact factor: 2.388

3.  Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes.

Authors:  Andrea Henze; Katharina M Espe; Christoph Wanner; Vera Krane; Jens Raila; Berthold Hocher; Florian J Schweigert; Christiane Drechsler
Journal:  Diabetes Care       Date:  2012-08-24       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.